Chromatography in Biotechnology
This report aims to provide a comprehensive presentation of the global market for Chromatography ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Opioid Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Buprenorphine 1.2.3 Fentanyl 1.2.4 Hydrocodone 1.2.5 Morphine 1.2.6 Oxycodone 1.2.7 Tramadol 1.2.8 Others 1.3 Market by Application 1.3.1 Global Opioid Drugs Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Anesthesia 1.3.3 Pain relief 1.3.4 Cough suppression 1.3.5 Diarrhea suppression 1.3.6 Deaddiction 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Opioid Drugs Market Perspective (2018-2029) 2.2 Opioid Drugs Growth Trends by Region 2.2.1 Global Opioid Drugs Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Opioid Drugs Historic Market Size by Region (2018-2023) 2.2.3 Opioid Drugs Forecasted Market Size by Region (2024-2029) 2.3 Opioid Drugs Market Dynamics 2.3.1 Opioid Drugs Industry Trends 2.3.2 Opioid Drugs Market Drivers 2.3.3 Opioid Drugs Market Challenges 2.3.4 Opioid Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Opioid Drugs Players by Revenue 3.1.1 Global Top Opioid Drugs Players by Revenue (2018-2023) 3.1.2 Global Opioid Drugs Revenue Market Share by Players (2018-2023) 3.2 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Opioid Drugs Revenue 3.4 Global Opioid Drugs Market Concentration Ratio 3.4.1 Global Opioid Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Opioid Drugs Revenue in 2022 3.5 Opioid Drugs Key Players Head office and Area Served 3.6 Key Players Opioid Drugs Product Solution and Service 3.7 Date of Enter into Opioid Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Opioid Drugs Breakdown Data by Type 4.1 Global Opioid Drugs Historic Market Size by Type (2018-2023) 4.2 Global Opioid Drugs Forecasted Market Size by Type (2024-2029) 5 Opioid Drugs Breakdown Data by Application 5.1 Global Opioid Drugs Historic Market Size by Application (2018-2023) 5.2 Global Opioid Drugs Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Opioid Drugs Market Size (2018-2029) 6.2 North America Opioid Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Opioid Drugs Market Size by Country (2018-2023) 6.4 North America Opioid Drugs Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Opioid Drugs Market Size (2018-2029) 7.2 Europe Opioid Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Opioid Drugs Market Size by Country (2018-2023) 7.4 Europe Opioid Drugs Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Opioid Drugs Market Size (2018-2029) 8.2 Asia-Pacific Opioid Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Opioid Drugs Market Size by Region (2018-2023) 8.4 Asia-Pacific Opioid Drugs Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Opioid Drugs Market Size (2018-2029) 9.2 Latin America Opioid Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Opioid Drugs Market Size by Country (2018-2023) 9.4 Latin America Opioid Drugs Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Opioid Drugs Market Size (2018-2029) 10.2 Middle East & Africa Opioid Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Opioid Drugs Market Size by Country (2018-2023) 10.4 Middle East & Africa Opioid Drugs Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Acura Pharmaceuticals 11.1.1 Acura Pharmaceuticals Company Detail 11.1.2 Acura Pharmaceuticals Business Overview 11.1.3 Acura Pharmaceuticals Opioid Drugs Introduction 11.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2018-2023) 11.1.5 Acura Pharmaceuticals Recent Development 11.2 Cipher Pharmaceutical Inc. 11.2.1 Cipher Pharmaceutical Inc. Company Detail 11.2.2 Cipher Pharmaceutical Inc. Business Overview 11.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction 11.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2018-2023) 11.2.5 Cipher Pharmaceutical Inc. Recent Development 11.3 Daiichi Sankyo 11.3.1 Daiichi Sankyo Company Detail 11.3.2 Daiichi Sankyo Business Overview 11.3.3 Daiichi Sankyo Opioid Drugs Introduction 11.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2018-2023) 11.3.5 Daiichi Sankyo Recent Development 11.4 Johnson&Johnson 11.4.1 Johnson&Johnson Company Detail 11.4.2 Johnson&Johnson Business Overview 11.4.3 Johnson&Johnson Opioid Drugs Introduction 11.4.4 Johnson&Johnson Revenue in Opioid Drugs Business (2018-2023) 11.4.5 Johnson&Johnson Recent Development 11.5 Lupin Limited 11.5.1 Lupin Limited Company Detail 11.5.2 Lupin Limited Business Overview 11.5.3 Lupin Limited Opioid Drugs Introduction 11.5.4 Lupin Limited Revenue in Opioid Drugs Business (2018-2023) 11.5.5 Lupin Limited Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Detail 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Opioid Drugs Introduction 11.6.4 Pfizer Revenue in Opioid Drugs Business (2018-2023) 11.6.5 Pfizer Recent Development 11.7 Sun Pharmaceuticals 11.7.1 Sun Pharmaceuticals Company Detail 11.7.2 Sun Pharmaceuticals Business Overview 11.7.3 Sun Pharmaceuticals Opioid Drugs Introduction 11.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2018-2023) 11.7.5 Sun Pharmaceuticals Recent Development 11.8 Teva Pharmaceutical Industries Ltd. 11.8.1 Teva Pharmaceutical Industries Ltd. Company Detail 11.8.2 Teva Pharmaceutical Industries Ltd. Business Overview 11.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction 11.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2018-2023) 11.8.5 Teva Pharmaceutical Industries Ltd. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Opioid Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Buprenorphine Table 3. Key Players of Fentanyl Table 4. Key Players of Hydrocodone Table 5. Key Players of Morphine Table 6. Key Players of Oxycodone Table 7. Key Players of Tramadol Table 8. Key Players of Others Table 9. Global Opioid Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 10. Global Opioid Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 11. Global Opioid Drugs Market Size by Region (2018-2023) & (US$ Million) Table 12. Global Opioid Drugs Market Share by Region (2018-2023) Table 13. Global Opioid Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 14. Global Opioid Drugs Market Share by Region (2024-2029) Table 15. Opioid Drugs Market Trends Table 16. Opioid Drugs Market Drivers Table 17. Opioid Drugs Market Challenges Table 18. Opioid Drugs Market Restraints Table 19. Global Opioid Drugs Revenue by Players (2018-2023) & (US$ Million) Table 20. Global Opioid Drugs Market Share by Players (2018-2023) Table 21. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2022) Table 22. Ranking of Global Top Opioid Drugs Companies by Revenue (US$ Million) in 2022 Table 23. Global 5 Largest Players Market Share by Opioid Drugs Revenue (CR5 and HHI) & (2018-2023) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Opioid Drugs Product Solution and Service Table 26. Date of Enter into Opioid Drugs Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Opioid Drugs Market Size by Type (2018-2023) & (US$ Million) Table 29. Global Opioid Drugs Revenue Market Share by Type (2018-2023) Table 30. Global Opioid Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 31. Global Opioid Drugs Revenue Market Share by Type (2024-2029) Table 32. Global Opioid Drugs Market Size by Application (2018-2023) & (US$ Million) Table 33. Global Opioid Drugs Revenue Market Share by Application (2018-2023) Table 34. Global Opioid Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 35. Global Opioid Drugs Revenue Market Share by Application (2024-2029) Table 36. North America Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. North America Opioid Drugs Market Size by Country (2018-2023) & (US$ Million) Table 38. North America Opioid Drugs Market Size by Country (2024-2029) & (US$ Million) Table 39. Europe Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 40. Europe Opioid Drugs Market Size by Country (2018-2023) & (US$ Million) Table 41. Europe Opioid Drugs Market Size by Country (2024-2029) & (US$ Million) Table 42. Asia-Pacific Opioid Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 43. Asia-Pacific Opioid Drugs Market Size by Region (2018-2023) & (US$ Million) Table 44. Asia-Pacific Opioid Drugs Market Size by Region (2024-2029) & (US$ Million) Table 45. Latin America Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Latin America Opioid Drugs Market Size by Country (2018-2023) & (US$ Million) Table 47. Latin America Opioid Drugs Market Size by Country (2024-2029) & (US$ Million) Table 48. Middle East & Africa Opioid Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 49. Middle East & Africa Opioid Drugs Market Size by Country (2018-2023) & (US$ Million) Table 50. Middle East & Africa Opioid Drugs Market Size by Country (2024-2029) & (US$ Million) Table 51. Acura Pharmaceuticals Company Detail Table 52. Acura Pharmaceuticals Business Overview Table 53. Acura Pharmaceuticals Opioid Drugs Product Table 54. Acura Pharmaceuticals Revenue in Opioid Drugs Business (2018-2023) & (US$ Million) Table 55. Acura Pharmaceuticals Recent Development Table 56. Cipher Pharmaceutical Inc. Company Detail Table 57. Cipher Pharmaceutical Inc. Business Overview Table 58. Cipher Pharmaceutical Inc. Opioid Drugs Product Table 59. Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2018-2023) & (US$ Million) Table 60. Cipher Pharmaceutical Inc. Recent Development Table 61. Daiichi Sankyo Company Detail Table 62. Daiichi Sankyo Business Overview Table 63. Daiichi Sankyo Opioid Drugs Product Table 64. Daiichi Sankyo Revenue in Opioid Drugs Business (2018-2023) & (US$ Million) Table 65. Daiichi Sankyo Recent Development Table 66. Johnson&Johnson Company Detail Table 67. Johnson&Johnson Business Overview Table 68. Johnson&Johnson Opioid Drugs Product Table 69. Johnson&Johnson Revenue in Opioid Drugs Business (2018-2023) & (US$ Million) Table 70. Johnson&Johnson Recent Development Table 71. Lupin Limited Company Detail Table 72. Lupin Limited Business Overview Table 73. Lupin Limited Opioid Drugs Product Table 74. Lupin Limited Revenue in Opioid Drugs Business (2018-2023) & (US$ Million) Table 75. Lupin Limited Recent Development Table 76. Pfizer Company Detail Table 77. Pfizer Business Overview Table 78. Pfizer Opioid Drugs Product Table 79. Pfizer Revenue in Opioid Drugs Business (2018-2023) & (US$ Million) Table 80. Pfizer Recent Development Table 81. Sun Pharmaceuticals Company Detail Table 82. Sun Pharmaceuticals Business Overview Table 83. Sun Pharmaceuticals Opioid Drugs Product Table 84. Sun Pharmaceuticals Revenue in Opioid Drugs Business (2018-2023) & (US$ Million) Table 85. Sun Pharmaceuticals Recent Development Table 86. Teva Pharmaceutical Industries Ltd. Company Detail Table 87. Teva Pharmaceutical Industries Ltd. Business Overview Table 88. Teva Pharmaceutical Industries Ltd. Opioid Drugs Product Table 89. Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2018-2023) & (US$ Million) Table 90. Teva Pharmaceutical Industries Ltd. Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Opioid Drugs Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Opioid Drugs Market Share by Type: 2022 VS 2029 Figure 3. Buprenorphine Features Figure 4. Fentanyl Features Figure 5. Hydrocodone Features Figure 6. Morphine Features Figure 7. Oxycodone Features Figure 8. Tramadol Features Figure 9. Others Features Figure 10. Global Opioid Drugs Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 11. Global Opioid Drugs Market Share by Application: 2022 VS 2029 Figure 12. Anesthesia Case Studies Figure 13. Pain relief Case Studies Figure 14. Cough suppression Case Studies Figure 15. Diarrhea suppression Case Studies Figure 16. Deaddiction Case Studies Figure 17. Others Case Studies Figure 18. Opioid Drugs Report Years Considered Figure 19. Global Opioid Drugs Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 20. Global Opioid Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 21. Global Opioid Drugs Market Share by Region: 2022 VS 2029 Figure 22. Global Opioid Drugs Market Share by Players in 2022 Figure 23. Global Top Opioid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2022) Figure 24. The Top 10 and 5 Players Market Share by Opioid Drugs Revenue in 2022 Figure 25. North America Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. North America Opioid Drugs Market Share by Country (2018-2029) Figure 27. United States Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Canada Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Europe Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Europe Opioid Drugs Market Share by Country (2018-2029) Figure 31. Germany Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. France Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. U.K. Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Italy Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Russia Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Nordic Countries Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Asia-Pacific Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Asia-Pacific Opioid Drugs Market Share by Region (2018-2029) Figure 39. China Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Japan Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. South Korea Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Southeast Asia Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. India Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Australia Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Latin America Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Latin America Opioid Drugs Market Share by Country (2018-2029) Figure 47. Mexico Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. Brazil Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 49. Middle East & Africa Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 50. Middle East & Africa Opioid Drugs Market Share by Country (2018-2029) Figure 51. Turkey Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 52. Saudi Arabia Opioid Drugs Market Size YoY Growth (2018-2029) & (US$ Million) Figure 53. Acura Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2018-2023) Figure 54. Cipher Pharmaceutical Inc. Revenue Growth Rate in Opioid Drugs Business (2018-2023) Figure 55. Daiichi Sankyo Revenue Growth Rate in Opioid Drugs Business (2018-2023) Figure 56. Johnson&Johnson Revenue Growth Rate in Opioid Drugs Business (2018-2023) Figure 57. Lupin Limited Revenue Growth Rate in Opioid Drugs Business (2018-2023) Figure 58. Pfizer Revenue Growth Rate in Opioid Drugs Business (2018-2023) Figure 59. Sun Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2018-2023) Figure 60. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Opioid Drugs Business (2018-2023) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed
Acura Pharmaceuticals Cipher Pharmaceutical Inc. Daiichi Sankyo Johnson&Johnson Lupin Limited Pfizer Sun Pharmaceuticals Teva Pharmaceutical Industries Ltd.
This report aims to provide a comprehensive presentation of the global market for Chromatography ... Read More
This report aims to provide a comprehensive presentation of the global market for High Content Im ... Read More
This report aims to provide a comprehensive presentation of the global market for Lysosomal Disea ... Read More
This report aims to provide a comprehensive presentation of the global market for Assistive Devic ... Read More